The Morning Dispatch: A Trump-GOP Temperature Check

Happy Wednesday! If you’re still a little groggy this morning, check out this video of White House staffers repeatedly shouting “Thank you!” over reporters trying to ask President Joe Biden and Prime Minister Boris Johnson questions at the White House yesterday. We promise it’ll wake you right up.

Quick Hits: Today’s Top Stories

  • Johnson & Johnson released the results of a Phase 3 study on Tuesday showing that a single dose of its COVID-19 vaccine remained 79 percent effective against infection and 81 percent effective against hospitalization—even as the Delta variant became the dominant strain in the United States. The data also showed that a booster dose—given 56 days after the initial one—increased effectiveness against symptomatic illness to 94 percent in the United States and effectiveness against severe COVID-19 to 100 percent. J&J said it plans to submit the data to public health regulators for consideration.

  • The House voted along party lines last night to advance legislation that would fund the federal government through December 2021 and suspend the debt ceiling through December 2022. The package is likely doomed in the Senate, where it needs 60 votes to get to President Biden’s desk and Republicans have made clear they will not support it. Sens. Mitch McConnell and Richard Shelby introduced a competing short-term government funding bill Tuesday night that did not include a suspension of the debt limit.

  • The European Court of Human Rights ruled on Tuesday that Russia was responsible for the fatal 2006 poisoning of former KGB officer Aleksandr Litvinenko, who fled Russia after being fired from the country’s security service and was granted asylum in the United Kingdom.

This content is available exclusively to Dispatch members
Try a membership for full access to every newsletter and all of The Dispatch. Support quality, fact-based journalism.
Already a paid member? Sign In
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.